Who We Are

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry Lime Rickey) as well as an ongoing Pharmaceutical Development initiative (Proposed Anti-Nausea Product).

Management Team

Seth M. Shaw

Chief Executive Officer

Mr. Shaw has extensive experience building companies and securing financing from a broad array of both domestic and international institutional investors… Read more Mr. Shaw has extensive experience building companies and securing financing from a broad array of both domestic and international institutional investors. Over the past fifteen years, he has been instrumental in securing more than $100 million in capital, in aggregate, for a number ofl small-cap and micro-cap companies (both publicly traded and privately held).

Mr. Shaw started his career at American International Group (AIG) Global Investment Group, after which he gained further experience working at a prestigious Manhattan based hedge fund. In 2005, he founded Novastar Resources Ltd, a natural resources exploration company focused on the exploration and acquisition of mineral properties containing the element thorium (Th). During this period, Mr. Shaw secured more than $17 million in financing from top tier institutional investors and helped complete the merger between Novastar Resources and Thorium Power, holding the position of Director of Strategic Planning until mid-2007. Subsequently, the company changed its name to Lightbridge Inc. and currently trades on the NASDAQ – under the ticker symbol: LTBR.

Following the above-referenced merger, Mr. Shaw has assisted several other companies in securing value added capital from institutional investors as well as providing management consulting services. Among those, Mr. Shaw was instrumental in securing $12,000,000 for a NASDAQ listed flat panel color display developer.  In addition Mr. Shaw served as the founding CFO of a Los Angeles based Biotech firm which announced plans for a $118 million NASDAQ IPO in February of 2011.

More recently Mr. Shaw has served as President and CEO of OTCQB Listed Tauriga Sciences Inc., since July 2015, during which time he secured a $2,000,000+ cash Settlement (Insurance Settlement) for the Company and launched its Tauri-Gum™ product line (Proprietary – Cannabidiol -CBD- & Cannabigerol -CBG- Infused Chewing Gum).  The Tauri-Gum™ product line consists of 7 distinct flavors/versions: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry Lime Rickey.  He has created a multi faceted business model for Tauriga that has resulted in both revenue growth, vertical opportunities, and a strong balance sheet.  Also during his period, Mr. Shaw has served as a Consultant for a NASDAQ listed Biotech firm developing a novel drug candidate for the treatment of Major Depressive Disorder.

Mr. Shaw graduated from Cornell University in 2001, with a degree in Policy Analysis Management and a concentration in Econometrics. Mr. Shaw has served on the Board of Directors of a number of important entities and initiatives, including but not limited to:  the Jewish Community Center (JCC) of Dutchess County NY (2005-2015), Save A Child’s Heart (“SACH”) New York City Leadership Group (2012-2017), The Cypress Fund for World Peace and Security (2006-2010), and has been active in numerous charities and not for profits, including: The Robinhood Foundation (2007-2009).

Kevin Lacey

Chief Financial Officer

Kevin Lacey is an experienced finance professional with over twenty year’s experience working with small and large companies leading financial teams, implementing… Read more Kevin Lacey is an experienced finance professional with over twenty year’s experience working with small and large companies leading financial teams, implementing and converting accounting systems, designing and implementing controls, inventory system implementation and management as well as vast experience in preparing financial statements, budgeting and financial analysis.

Over the past five years, Kevin, as head of Mariner Consulting Group Inc., has worked with numerous small reporting public companies in financial statement preparation and consulting as well as assisting many small private companies with accounting system design and implementation along with business development consulting.

Kevin is a Certified Public Accountant (CPA) as registered with the State of Florida. He holds a Masters in Business Administration (MBA) from that University of Central Florida (1999) as well as a Bachelors in the Science of Accounting from Webber International University (1993).

Kevin is also an U.S. Military Veteran, serving in the U.S. Army from 1987 to 1989. He was honorably discharged in 1989.

Adina Miles

Chief Marketing Officer

Adina Miles initially gained notoriety in the marketing world by developing the satirical persona FlatbushGirl and garnering tens of thousands of social… Read more Adina Miles initially gained notoriety in the marketing world by developing the satirical persona FlatbushGirl and garnering ten of thousands of social media followers and millions of video views. Since then, she has spearheaded marketing projects for political campaigns, consulted with numerous businesses on social media strategies, and has received front page news press through her activism of women’s rights.

Adina was initially brought in to grow the Tauri-Gum B2C e-commerce presence and has since moved into product development and raising additional capital for Tauriga Sciences.

In her free time,  Adina is a political and social activist, social media influencer, and a volunteer EMT.

Dr Keith Aqua

Chief Medical Officer

As Chief Medical Officer, Keith A. Aqua, MD brings more than 25 years of industry experience as a private practitioner and certified clinical investigator to Tauriga Sciences…Read more As Chief Medical Officer, Keith A. Aqua, MD brings more than 25 years of industry experience as a private practitioner and certified clinical investigator to Tauriga Sciences. Alongside his clinical research, Dr. Aqua is a board-certified obstetrician/gynecologist with a thriving private practice in West Palm Beach, Florida. He received a B.A. from the University of Pennsylvania and an M.D. from The Ohio State University. After completing his residency at the University of Arizona Health Sciences Center, he co-founded the Institute for Women’s Health and Body, a large single specialty group located in Palm Beach County, Florida. In 2001, he founded Visions Clinical Research and in 2015 the Atlantic Clinical Research Collaborative. He has been a Principal Investigator on over 300 pharmaceutical industry-sponsored clinical trials. He has received numerous teaching awards and has a number of publications and citations related to research in women’s health, dermatology, and family medicine. He is currently a speaker for several pharmaceutical companies and is an adjunct clinical professor at the Charles E. Schmidt College of Medicine at Florida Atlantic University.

Board of Directors

Seth M. Shaw

Mr. Shaw has extensive experience building companies and securing financing from a broad array of both domestic and international institutional investors… Read more Mr. Shaw has extensive experience building companies and securing financing from a broad array of both domestic and international institutional investors. Over the past fifteen years, he has been instrumental in securing more than $100 million in capital, in aggregate, for a number ofl small-cap and micro-cap companies (both publicly traded and privately held).

Mr. Shaw started his career at American International Group (AIG) Global Investment Group, after which he gained further experience working at a prestigious Manhattan based hedge fund. In 2005, he founded Novastar Resources Ltd, a natural resources exploration company focused on the exploration and acquisition of mineral properties containing the element thorium (Th). During this period, Mr. Shaw secured more than $17 million in financing from top tier institutional investors and helped complete the merger between Novastar Resources and Thorium Power, holding the position of Director of Strategic Planning until mid-2007. Subsequently, the company changed its name to Lightbridge Inc. and currently trades on the NASDAQ – under the ticker symbol: LTBR.

Following the above-referenced merger, Mr. Shaw has assisted several other companies in securing value added capital from institutional investors as well as providing management consulting services. Among those, Mr. Shaw was instrumental in securing $12,000,000 for a NASDAQ listed flat panel color display developer.  In addition Mr. Shaw served as the founding CFO of a Los Angeles based Biotech firm which announced plans for a $118 million NASDAQ IPO in February of 2011.

More recently Mr. Shaw has served as President and CEO of OTCQB Listed Tauriga Sciences Inc., since July 2015, during which time he secured a $2,000,000+ cash Settlement (Insurance Settlement) for the Company and launched its Tauri-Gum™ product line (Proprietary – Cannabidiol -CBD- & Cannabigerol -CBG- Infused Chewing Gum).  The Tauri-Gum™ product line consists of 7 distinct flavors/versions: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry Lime Rickey.  He has created a multi faceted business model for Tauriga that has resulted in both revenue growth, vertical opportunities, and a strong balance sheet.  Also during his period, Mr. Shaw has served as a Consultant for a NASDAQ listed Biotech firm developing a novel drug candidate for the treatment of Major Depressive Disorder.

Mr. Shaw graduated from Cornell University in 2001, with a degree in Policy Analysis Management and a concentration in Econometrics. Mr. Shaw has served on the Board of Directors of a number of important entities and initiatives, including but not limited to:  the Jewish Community Center (JCC) of Dutchess County NY (2005-2015), Save A Child’s Heart (“SACH”) New York City Leadership Group (2012-2017), The Cypress Fund for World Peace and Security (2006-2010), and has been active in numerous charities and not for profits, including: The Robinhood Foundation (2007-2009).

Thomas Graham

Director of Operations for Sears and Roebuck a national retailer with stores nation wide. Over see direct operations for all departments their managers and…Read more Director of Operations for Sears and Roebuck a national retailer with stores nation wide. Over see direct operations for all departments their managers and associates. Accountable for all sales, labor and operation standards as set by Sears Corporate. Results oriented Marketing and Sales Director for a major Michigan retail supermarket with sales in excess of $100,000,000.00 annually. Over see all print and visual advertising including newspaper, radio and television. Work with local and national vendors to promote and increase sales and customer flow. Store Manager with successful experience managing multiple unit organizations.

Analyzed market conditions, buying trends and competitor challenges to gain market share. Recruited, trained and developed employees and built self sustaining teams to ensure customer satisfaction. Exceed yearly sales and profit goals for the continued success of each unit under my supervision.

Specialties: P&L / Inventory & Cost Control / Performance Management / Store Design / Labor Management / Recruiting / Retention / Procurement / Customer Satisfaction / Training & Development / Sales Management / Turn around of struggling units.

Dr. David Wolitzky

Dr. Wolitzky received his BA from The City College of New York (1957) and his Ph.D. in Clinical Psychology from the University of Rochester (1961). He is also a… Read more Dr. Wolitzky received his BA from The City College of New York (1957) and his Ph.D. in Clinical Psychology from the University of Rochester (1961). He is also a graduate of the New York Psychoanalytic Institute (1972). Since 1974 Dr. Wolitzky has been a tenured faculty member in the Department of Psychology, New York University. His many years there of teaching, research, supervisory, and administrative experience included serving as the Director of the Clinical Psychology Ph.D. Program, the N.Y.U Psychology Clinic, and as a Co-Director of the N.Y.U. Postdoctoral Program in Psychotherapy and Psychoanalysis and as a supervisor of candidates in training. His other professional activities include publication of numerous articles and book chapters, edited books, forensic evaluation in child custody cases, psychological assessments of individuals being considered for high-level executive positions in industry, extensive experience as a book editor, and the practice of psychotherapy. He also has served on the New State Board of Psychology, Office of Professional Discipline.

Advisory Board

General Fogleman

General Ronald R. Fogleman (“General Fogleman”) is a highly decorated combat veteran who retired from the United States Air Force (“U.S. Air Force”… Read more General Ronald R. Fogleman (“General Fogleman”) is a highly decorated combat veteran who retired from the United States Air Force (“U.S. Air Force” or “USAF”) after 34 years active commissioned service. On his final tour of duty he served as the 15th Chief of Staff of the U.S. Air Force and a member of the Joint Chiefs of Staff (“JCS”) during the administration of President Clinton. Prior to that assignment he was Commander in Chief of the United States Transportation Command (“CINCTRANS”). As Chief of Staff, he served as the senior uniformed officer responsible for the organization, training and equipage of 750,000 active duty, Guard, Reserve and civilian forces serving in the United States and Overseas. As a member of the JCS, he served as a military advisor to the Secretary of Defense, the National Security Council and the President. Since retiring from the U.S. Air Force, General Fogleman has served on the Defense Policy Board, The National Aeronautics and Space Administration (“NASA”) Advisory Council, the Jet Propulsion Laboratory Advisory Board, chaired an Air Force Laboratory study on directed energy weapons, chaired a National Resource Committee on Aeronautics Research and Technology for Vision 2050: An integrated Transportation System, served on the NASA Mars Program Independent Assessment Team, the congressionally directed Commission to Assess United States National Security Space Management and Organization, the NASA Shuttle Return to Flight Task Group and the Independent Assessment Panel to examine the Management and Organization of National Security Space Assets.

General Fogleman has served on and chaired several public and private company boards. He is currently the Chairman of the Board of Alliant Techsystems Inc. (NYSE: ATK), the Lead Director on the Board of Directors for AAR Corp. (NYSE: AIR), and serves on the boards of AGC Composites and Aerostructures, First National Bank of Durango, MITRE Corporation, Tactical Air Support, Inc. and Thayles-Raytheon Systems. he has served as the chair of Audit and Governance Committees throughout his career in the public and private sectors.

He devotes considerable time to national security, governance of public companies and community affairs. He is a member of the National Association of Corporate Directors, Council on Foreign Relations, Falcon Foundation, Airlift Tanker Association, Fort Lewis College Foundation, and the Air Force Association. He lectures on leadership, international affairs and military issues and has published numerous articles on air and space operations.